KeyGene, Genalice Ink Licensing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Plant genomics firm KeyGene and startup bioinformatics company Genalice today announced a deal aimed at improving plant DNA analysis.

As part of the agreement, KeyGene will license Genalice MAP, a short-read alignment tool, which processes raw next-generation sequencing data into a small and easily manageable file for low-cost storage or further analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.